Topics

Increasing Antipsychotic Dose Versus Switching Antipsychotic for Non Response in Schizophrenia (Review).

07:00 EST 14th January 2020 | BioPortfolio

Summary of "Increasing Antipsychotic Dose Versus Switching Antipsychotic for Non Response in Schizophrenia (Review)."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Issues in mental health nursing
ISSN: 1096-4673
Pages: 1-2

Links

DeepDyve research library

PubMed Articles [16285 Associated PubMed Articles listed on BioPortfolio]

The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment.

Recent findings suggest that cognitive impairment can be associated with inflammation and immune changes in schizophrenia. We aimed to study possible associations between cytokine levels and cognitive...

The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.

The response to antipsychotic treatment in schizophrenia appears to vary, and as such it has been proposed that different subtypes of schizophrenia exist, defined by treatment-response. This has not b...

Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.

This study compared the risk of hospitalization among adults with schizophrenia being treated with equivalent dose ranges of lurasidone versus aripiprazole, olanzapine, quetiapine, or risperidone. Adm...

Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.

This systematic review and meta-analysis examined predictors of successful antipsychotic dose reduction in schizophrenia. Prospective clinical trials and randomized controlled trials (RCTs) investigat...

A National Database Study on the Use of Long-Acting Antipsychotic Injections and Hospital Readmission Proportions in Patients with Schizophrenia in Japan.

It is important to investigate the current prescription status and clinical outcomes of patients with schizophrenia receiving long-acting antipsychotic injections. We aimed to determine the prescripti...

Clinical Trials [15666 Associated Clinical Trials listed on BioPortfolio]

The Switch Study - Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

The main aim of the trial is to study whether a change of medication in non-responders to a two-weeks antipsychotic drug trial is more effective than continued treatment with the same anti...

Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

The purpose of this study is to determine whether moderately ill Asian schizophrenic patients can be switched from their previous antipsychotic medication to aripiprazole with minimal adve...

Switching Medication to Treat Schizophrenia

This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatme...

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

The purpose of this study is to assess the 14-day and 12-week safety and efficacy of Depakote ER used in combination with either olanzapine or risperidone versus antipsychotic monotherapy ...

Antipsychotic Polypharmacy in Schizophrenia

The literature suggests that when a patient is prescribed more than one antipsychotic for at least 30 days, he or she is likely to continue on that combination. In this 12 week study 100 a...

Medical and Biotech [MESH] Definitions

An antipsychotic agent used in schizophrenia.

A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.

A long-acting injectable antipsychotic agent used for chronic schizophrenia.

An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.

One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.

Quick Search


DeepDyve research library

Relevant Topic

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...


Searches Linking to this Article